Gilead Sciences, Inc.
NASDAQ:GILD ISIN:US3755581036
Gilead Sciences, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of human therapeutics for life threatening diseases.
View in Other Languages
News
Agenix Limited (ASX:AGX) today confirmed it had signed two new agreements with its strategic partners in China covering the commercialisation of new drug candidates, the sharing of resources, expertise and completion of pre-clinical toxicology tests for its new hepatitis B drug in China.
Agenix Limited (ASX:AGX) confirmed its promising new hepatitis B drug, AGX-1009, shared the same active compound as Gilead's blockbuster drug, Viread, which is widely used to treat HIV and hepatitis throughout Asia.
###
34,421 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 9) (Last 30 Days: 53) (Since Published: 9000)
